Formulation Development
Hovione & iBET Announce the Establishment of a Venture in Cell & Gene Therapy Solutions
Hovione and iBET recently announced the official establishment of ViSync Technologies as a jointly owned venture. The creation of this new company, headquartered in the…
Lonza Launches Innovaform Accelerator, the New Innovation & Formulation Center in Colmar (FR)
Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, recently inaugurated its new facility at the Colmar (FR) site. The new Innovaform…
Tiziana Life Sciences Announces $4-Million Grant to Study Anti-CD3 in Alzheimer’s Disease
Tiziana Life Sciences, Ltd. recently announced the National Institutes of Health (NIH), National Institute on Aging have awarded a $4-million grant to Dr. Howard Weiner…
Oncolytics Biotech Reports Favorable Results for BRACELET-1 Breast Cancer Study
Oncolytics Biotech Inc. recently announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep in patients with HR+/HER2- advanced or metastatic breast cancer.…
PlaqueTec & RxCelerate Collaborate on Early Phase Drug Discovery for Coronary Artery Disease
PlaqueTec and RxCelerate recently announced the successful completion of a collaboration to assess small molecules identified from an initial cheminformatics drug screen in a bespoke…
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
Certara, Inc. recently shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001. IGI’s…
Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
Sonnet BioTherapeutics Holdings, Inc. recently announced the completion of enrollment and initiation of dosing in its Phase 1 SB101 clinical trial of SON-1010 (IL12-FHAB) in…
Asimov Launches a Suite of AI Models, Host Cells & Genetic Tools for End-to-End Gene Therapy Development
[caption id="attachment_143234" align="alignleft" width="170"] AAV Edge[/caption] Asimov recently announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV)…
Adare & Laxxon AnnouNce 3D-Printing Collaboration
Adare Pharma Solutions recently announced a collaboration with Laxxon Medical to provide the pharmaceutical market with cGMP 3D printing capabilities from Adare’s Pessano facility in…
CoreRx, Societal CDMO & Bend Bioscience Unite Under the Bend Bioscience Brand to Provide World Class CDMO Offering
In a significant move, CoreRx, Societal CDMO, and Bend Bioscience have announced their unification under the Bend Bioscience brand. This merger brings together three highly…
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial With First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics, Inc. recently announced dosing of the first two patients in its Phase 1 clinical trial with its lead candidate, TTX-MC138. Several additional patients…
Cullinan Therapeutics Receives Approval to Initiate its Global Phase 1 Clinical Trial for the Treatment of Systemic Lupus Erythematosus
Cullinan Therapeutics, Inc. received Human Research Ethics Committee (HREC) approval in Australia to initiate its global Phase 1 clinical trial to evaluate CLN-978, its CD19xCD3 bispecific…
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b Trial
AC Immune SA recently announced it will receive the second ReTain-related milestone payment (CHF 24.6 million) under its agreement with Janssen Pharmaceuticals, Inc. (Janssen), a…
ImmuneSensor Therapeutics Granted New US Patent for its Oral cGAS Inhibitors
ImmuneSensor Therapeutics recently announced the United States Patent and Trademark Office (USPTO) has issued US patent No. 12,091,387 containing claims covering compositions of matter and…
Molex Announces Agreement to Acquire the Vectura Group Limited, Expanding its Drug Delivery Capabilities in Inhalation
Molex, a parent to Phillips Medisize, a leader in the design, engineering, and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, recently…
Atsena Therapeutics Receives Orphan Drug Designation for Gene Therapy to Treat X-linked Retinoschisis
Atsena Therapeutics recently announced the US FDA has granted Orphan Drug Designation for ATSN-201 for the treatment of X-linked retinoschisis (XLRS). ATSN-201, a best-in-class gene…
Orbis Medicines & Vivtex Form Research & Exclusive Licensing Collaboration
Orbis Medicines recently announced a research collaboration and option to an exclusive license with Vivtex, a biotech company aiming to transform the development of oral…
Serán Bioscience Announces $200-Million Strategic Growth Transaction & Plans for New Commercial Facility
Serán Bioscience recently announced a strategic growth transaction of more than $200 million. Bain Capital Life Sciences led the transaction, while existing investor Vivo Capital…
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
Athira Pharma, Inc. recently announced that following the topline data readout from the Phase 2/3 LIFT-AD clinical trial of fosgonimeton to treat Alzheimer’s disease (AD)…
Voyager Advances Collaboration With Neurocrine; Third Gene Therapy Development Candidate Selected
Voyager Therapeutics, Inc. recently announced that the joint steering committee with its collaborator Neurocrine Biosciences, Inc. has selected a development candidate in a gene therapy…
